Baldwin Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Baldwin Investment Management's EW Position: Q2 2026 in Review
Baldwin Investment Management reduced its Edwards Lifesciences (EW) stake by 4.1% in Q2 2026, selling an estimated $49.4K and leaving 13,730 shares worth $1.24M. The position accounts for 0.12% of the portfolio, ranked #98.
Baldwin Investment Management first reported a position in EW in Q3 2020 and has held it in 21 quarters since. The position peaked at $1.29M in Q4 2025. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Baldwin Investment Management held 13,730 shares of Edwards Lifesciences worth $1.24M as of Q2 2026.
- Baldwin Investment Management sold 590 Edwards Lifesciences shares in Q2 2026, an estimated $49.4K.
- Edwards Lifesciences made up 0.12% of Baldwin Investment Management's portfolio in Q2 2026, its #98 holding.
- Baldwin Investment Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 21 quarters since.
- Baldwin Investment Management's Edwards Lifesciences position peaked at $1.29M in Q4 2025.
- 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.